| Epidermal growth factor receptor and its role in pancreatic cancer treatment mediated by nanoparticles CM Grapa, T Mocan, D Gonciar, C Zdrehus, O Mosteanu, T Pop, L Mocan International journal of nanomedicine, 9693-9706, 2019 | 48 | 2019 |
| Liver injury and elevated FIB-4 define a high-risk group in patients with COVID-19 D Crisan, L Avram, C Grapa, A Dragan, D Radulescu, S Crisan, A Grosu, ... Journal of Clinical Medicine 11 (1), 153, 2021 | 20 | 2021 |
| Carbon nanotubes-based assays for cancer detection and screening C Bura, T Mocan, C Grapa, L Mocan Pharmaceutics 14 (4), 781, 2022 | 17 | 2022 |
| Tetraspanins: Physiology, Colorectal Cancer Development, and Nanomediated Applications S Titu, CM Grapa, T Mocan, O Balacescu, A Irimie Cancers 13 (22), 5662, 2021 | 12 | 2021 |
| Digestive Toxicities Secondary to Immune Checkpoint Inhibition Therapy-Reports of Rare Events. A Systematic Review. L Radulescu, D Crisan, C Grapa, D Radulescu Journal of Gastrointestinal & Liver Diseases 30 (4), 2021 | 9 | 2021 |
| PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma LP Mocan, R Craciun, C Grapa, CS Melincovici, I Rusu, N Al Hajjar, ... Cancer Immunology, Immunotherapy 72 (4), 1003-1014, 2023 | 7 | 2023 |
| Recent advances in Nanoparticle-Mediated diagnosis and the treatment of pancreatic cancer A Nedelcu, T Mocan, C Grapa, L Mocan International Journal of Molecular Sciences 22 (15), 8060, 2021 | 7 | 2021 |
| Biomarkers in pancreatic cancer as analytic targets for nanomediated imaging and therapy CM Grapa, L Mocan, D Crisan, M Florea, T Mocan Materials 14 (11), 3083, 2021 | 5 | 2021 |
| Don’t Judge a Book by Its Cover: The Role of Statins in Liver Cancer N Piekuś-Słomka, LP Mocan, R Shkreli, C Grapă, K Denkiewicz, ... Cancers 15 (20), 5100, 2023 | 4 | 2023 |
| Gastrointestinal Manifestations and Treatment Options in Fabry Disease Patients. A Systematic Review. D Radulescu, D Crisan, V Militaru, E Buzdugan, L Stoicescu, A Grosu, ... Journal of Gastrointestinal & Liver Diseases 31 (1), 2022 | 3 | 2022 |
| Basic cardiovascular risk assessment in naïve patients with colon cancer L Radulescu, L Avram, E Buzdugan, D Crisan, A Grosu, C Grapa, ... Experimental and Therapeutic Medicine 23 (5), 1-7, 2022 | 2 | 2022 |
| Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis RJS Salzmann, C Krötz, T Mocan, LP Mocan, C Grapa, S Rottmann, ... Hepatology Communications 8 (3), e0380, 2024 | 1 | 2024 |
| Unveiling Health Inequalities: Exploring Metabolic Dysfunction in Rural Roma Communities D Crișan, L Avram, C Grapă, A Nemeș, MV Coman, MS Beldean-Galea, ... Healthcare 12 (8), 816, 2024 | | 2024 |
| A NOVEL 5-POINT SCORING SYSTEM FOR THE DIFFERENTIATION OF HCC FROM INTRAHEPATIC CCA IN LR-M PATIENTS RJS Salzmann, T Mocan, C Grapa, LP Mocan, B Wang, R Craciun, ... HEPATOLOGY 78, S100-S101, 2023 | | 2023 |
| STANDARD COAGULATION CUT-OFFS FOR INTERVENTIONAL PROCEDURES IN CIRRHOSIS-IS THROMBOELASTOGRAPHY RENDERING THEM OBSOLETE? MA Buliarcă, R Crăciun, B Procopeț, H Ștefănescu, I Nenu, C Grapă, ... Journal of Gastrointestinal & Liver Diseases 32, 2023 | | 2023 |
| Biomarkers in Pancreatic Cancer as Analytic Targets for Nanomediated Imaging and Therapy. Materials 2021, 14, 3083 CM Grapa, L Mocan, D Crisan, M Florea, T Mocan s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
